Navigation Links
Gamma globulin effective in treating eye infections caused by adenoviruses
Date:8/28/2007

PITTSBURGH, Aug. 28 Gamma globulin, a type of antibody isolated from blood samples that used to be routinely given to health care workers and international travelers to protect them from infectious diseases, is a highly effective treatment for pinkeye with little apparent toxicity, according to a study by researchers at the University of Pittsburgh School of Medicine. The results of the study, being published in the September 1 issue of the journal Investigative Ophthalmology and Visual Science and available online now, have significant implications for the treatment and prevention of eye diseases caused by adenovirus infections, such as conjunctivitis.

Conjunctivitis, commonly known as pinkeye, is an inflammation of the conjunctiva, the clear membrane that covers the white part of the eye and the inner surface of the eyelids. Although typically a mild, self-limiting disease in children and adults, newborns are particularly susceptible to pinkeye and can be more prone to serious health complications, even blindness, if it goes untreated. The most common cause of conjunctivitis is adenovirus infection. Unfortunately, current treatments for conjunctivitis are not specifically targeted to the virus, and, presently, there is no FDA-approved therapy for the treatment of adenoviral-mediated eye infections.

In the study, led by Andrea Gambotto, M.D., assistant professor of surgery, University of Pittsburgh School of Medicine, the researchers investigated the antiviral activity of gamma globulin (Ig) on human wild-type adenovirus as well as adenovirus subtypes isolated from patients diagnosed with viral eye infections. Specifically, they investigated the ability of Ig to neutralize these various adenovirus strains in both cell cultures infected with adenovirus and in rabbits with conjunctivitis.

In the cell culture (in vitro) studies, less than 10 milligrams per milliliter (mg/ml) of Ig significantly neutralized all of the wild-type str
'/>"/>

Contact: Jim Swyers
SwyersJP@upmc.edu
412-647-3555
University of Pittsburgh Schools of the Health Sciences
Source:Eurekalert

Page: 1 2

Related biology news :

1. Combination therapy boosts effectiveness of telomere-directed cancer cell death
2. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
3. First-ever Compounds To Target Only Metastatic Cells Are Highly Effective Against Breast, Prostate, And Colon Cancers
4. Boosting HIV screening can increase survival and is cost effective
5. Effective Cancer Treatments Follow The Clock
6. Live vaccines more effective against horse herpes virus
7. FDA Works To Speed The Advent Of New, More Effective Personalized Medicines
8. Man-made wetlands effectiveness similar to natural marsh
9. Wake Forest scientists find new combination vaccine effective against plague
10. UCLA study assesses cost-effectiveness of Hepatitis B drugs
11. Fungus Effective Against Winged Termites

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...ity have developed synthetic molecules capable of ...V-infected cells, as well as to prostate cancer ce...nal of the American Chemical Society , could lead .... , The molecules called "antibody-recruiting ...uiting molecule targeting prostate cancer" (ARM-P)...
(Date:11/4/2009)...tant to officially endorse green tea as a cancer p... its protective effects, including results of a ne... a journal of the American Association for Cancer ...ncer. , Vassiliki Papadimitrakopoulo, M.D., pro...ead and Neck Medical Oncology at the University of...
(Date:11/4/2009)...ng Beach and Riverside are responsible for a signi... and the true impact of air pollution and ship emi...ed, according to researchers at the University of ...ppears in an online edition of the American Journ...of all childhood asthma cases in Long Beach and si...
Breaking Biology News(10 mins):New synthetic molecules trigger immune response to HIV and prostate cancer 2Does green tea prevent cancer? Evidence continues to brew, but questions remain 2USC study finds big air pollution impacts on local communities 2Operation Rescue Announces Keep It Closed Campaign 53523 1Operation Rescue Announces Keep It Closed Campaign 53523 2TWO NEW KLRI PEER REVIEWED PUBLICATIONS 3A Hormone Therapy May Reduce Atherosclerosis in Women Close to Menopause 3B Growth Hormone May Increase Risk 4814 1TWO NEW KLRI PEER REVIEWED PUBLICATIONS 3A Hormone Therapy May Reduce Atherosclerosis in Women Close to Menopause 3B Growth Hormone May Increase Risk 4814 2TWO NEW KLRI PEER REVIEWED PUBLICATIONS 3A Hormone Therapy May Reduce Atherosclerosis in Women Close to Menopause 3B Growth Hormone May Increase Risk 4814 3Switch to digital mammography leads to increased cancer detection rates 53519 1
...cal rainforest interact with each other and their ...archers report in the Oct. 24 issue of the journal... forest dynamics plot of the Pontificia Universida...orest site associated with the Center for Tropical...th Observatory network (CTFS/SIGEO)., It is diffic...
... positive experience. However, by infecting the co... with a Salmonella strain known for causing human...ife Sciences at Arizona State University have shed... broad implications for understanding embryonic de... in humans. Associate Professor Stuart Newfeld and...
...to the mechanisms that underlie a pathological inc...ished by Cell Press in the October 24th issue of t...opment of new strategies for managing this extreme...t failure. , High blood pressure, heart valve dis...kening of the heart muscle, called myocardial hype...
Other Biology News:Diversity of trees in Ecuador's Amazon rainforest defies simple explanation 2Making flies sick reveals new role for growth factors in immunity 2Making flies sick reveals new role for growth factors in immunity 3Making flies sick reveals new role for growth factors in immunity 4Research uncovers new steps on pathway to enlarged heart 2
(Date:11/5/2009)...ITHERSBURG, Md., Nov. 5 ...financial results for the third quarter ended Sept... million ($0.04 per share) for the three months en...6.8 million ($0.08 per share) in the comparable qu... 30, 2009, GenVec,s net loss was $14.1 million ($0...
(Date:11/5/2009)...N DIEGO, Nov. 5 Imagenet...ay that William Spencer, President and CEO of Imag...the 2nd annual LD MICRO Conference on Thursday, De...Los Angeles. ,, About LD MICRO ,, LD MICRO i...s on finding undervalued companies in the micro-ca...
(Date:11/5/2009)...AHA, Neb., Nov. 5 Transg...unced financial results for the quarter ended Sept...e presented in the tables that follow. ,, Thir...oss of $366,000 or $0.01 per share for the third q...00 or $0.01 per share for the third quarter of 200...
(Date:11/5/2009)...RT WORTH, Texas, Nov. 5 ...nced today that it has entered into a Letter of In...Virtual Health Technologies, Inc. (OTC Bulletin Bo...$1,000,000 in cash and debt, 4,000,000 shares of W... by WNDM on the Veriscrip technology being acquire...
Breaking Biology Technology:GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 2OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 3
...New Flavor Ingredient Achieves ...ber 28, 2008 Senomyx,Inc. (Nasdaq: SNMX ), a lea...gies to discover and develop novel flavor ingredie...dustries, announced today that it has,received a p...ated to a,milestone achieved by Senomyx under the ...
...n Company,s Website -, TUSTIN, Calif., Oct. 28 P... clinical stage biopharmaceutical,company developi...er and,serious virus infections, today announced t...stor Forum 2008 on Thursday, October 30, 2008 at,3...eld at the Palace Hotel,in San Francisco., A live...
...patients with symptomatic Chronic,Obstructive Pulm...ta show reductions in moderate and severe exacerba...on for marketing authorisation in EU and US expect...ation in the US to be initiated, ZURICH, Switzerl...results from a preliminary analysis of four Phase ...
Other Biology Technology:SENOMYX ANNOUNCES RECEIPT OF MILESTONE PAYMENT FROM THE COCA-COLA COMPANY 2SENOMYX ANNOUNCES RECEIPT OF MILESTONE PAYMENT FROM THE COCA-COLA COMPANY 3Peregrine Pharmaceuticals to Present at BIO Investor Forum 2008 2Nycomed's Daxas(R) Shows Encouraging Preliminary Results in Phase III COPD Studies 2Nycomed's Daxas(R) Shows Encouraging Preliminary Results in Phase III COPD Studies 3
Baker's yeast (S. cerevisiae) Hexokinase and glucose-6-phosphate dehydrogenase from Sigma-Aldrich
...tibody Epitope: aa 16-25 of human GSK3 alpha. ...orage: Store vial at -20 C prior to opening. Dil...age aliquot contents and freeze at -20 C or below.... Other Sub-Family: not assigned-Other Appl...
Baker's yeast (S. cerevisiae) S-Acetyl-coenzyme A synthetase from Sigma-Aldrich
S-Protein Agarose from Novagen
Biology Products: